Literature DB >> 963439

Use of creatine kinase for detecting severe X-linked muscular dystrophy carriers.

N R Dennis, K Evans, B Clayton, C O Carter.   

Abstract

Women thought to be at risk of being carriers of Duchenne muscular dystrophy were given "odds" against their having an affected child. These were calcuated from a combination of the genetic risk from the family history and an estimation of the biochemical risk from measuring the serum creatine kinase concentration. The women were told the actual risk estimate and it was put into perspective for them as a high, medium, or low risk. Of 25 women at high risk six have had children, all girls; the two in the medium-risk group have had no children; and the 46 women at low risk have had 19 boys and 25 girls. None of the boys has the disease. With detailed counselling most potential carriers of this disease reach decisions in child bearing that are in line with their degree of risk.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 963439      PMCID: PMC1688064          DOI: 10.1136/bmj.2.6035.577

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  5 in total

1.  CREATINE KINASE LEVELS IN WOMEN WHO CARRY GENES FOR THREE TYPES OF MUSCULAR DYSTROPHY.

Authors:  K M WILSON; K A EVANS; C O CARTER
Journal:  Br Med J       Date:  1965-03-20

2.  Progressive Muscular Dystrophy. V. The Identification of the Carrier State in the Duchenne Type by Serum Creatine Kinase Determination.

Authors:  R Richterich; S Rosin; U Aebi; E Rossi
Journal:  Am J Hum Genet       Date:  1963-06       Impact factor: 11.025

3.  Pregnancy and serum C.P.K. levels in potential carriers of severe X-linked muscular dystrophy.

Authors:  H Blyth; B P Hughes
Journal:  Lancet       Date:  1971-04-24       Impact factor: 79.321

4.  Genetic counselling in X-linked muscular dystrophy.

Authors:  A E Emery
Journal:  J Neurol Sci       Date:  1969 May-Jun       Impact factor: 3.181

5.  The effects of genetic counselling in Duchenne muscular dystrophy.

Authors:  A E Emery; M S Watt; E R Clack
Journal:  Clin Genet       Date:  1972       Impact factor: 4.438

  5 in total
  5 in total

Review 1.  Duchenne muscular dystrophy: pathogenetic aspects and genetic prevention.

Authors:  H Moser
Journal:  Hum Genet       Date:  1984       Impact factor: 4.132

2.  The female carrier of Duchenne muscular dystrophy.

Authors:  V Dubowitz
Journal:  Br Med J (Clin Res Ed)       Date:  1982-05-15

3.  Use of overlapping normal distributions in genetic counselling.

Authors:  N R Dennis; C O Carter
Journal:  J Med Genet       Date:  1978-04       Impact factor: 6.318

4.  Carrier detection in Duchenne muscular dystrophy. Evidence from a study of obligatory carriers and mothers of isolated cases.

Authors:  J R Sibert; P S Harper; R J Thompson; R G Newcombe
Journal:  Arch Dis Child       Date:  1979-07       Impact factor: 3.791

5.  Service experience using DNA analysis for genetic prediction in Duchenne muscular dystrophy.

Authors:  J Goodship; S Malcolm; M E Robertson; M E Pembrey
Journal:  J Med Genet       Date:  1988-01       Impact factor: 6.318

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.